Page last updated: 2024-09-03

icrf 193 and alpha,beta-methyleneadenosine 5'-triphosphate

icrf 193 has been researched along with alpha,beta-methyleneadenosine 5'-triphosphate in 1 studies

Compound Research Comparison

Studies
(icrf 193)
Trials
(icrf 193)
Recent Studies (post-2010)
(icrf 193)
Studies
(alpha,beta-methyleneadenosine 5'-triphosphate)
Trials
(alpha,beta-methyleneadenosine 5'-triphosphate)
Recent Studies (post-2010) (alpha,beta-methyleneadenosine 5'-triphosphate)
1550301,0970100

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andoh, T; Berger, JM; Ishida, R; Roca, J; Wang, JC1

Other Studies

1 other study(ies) available for icrf 193 and alpha,beta-methyleneadenosine 5'-triphosphate

ArticleYear
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Mar-01, Volume: 91, Issue:5

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Diketopiperazines; DNA Topoisomerases, Type II; DNA, Circular; DNA, Fungal; Molecular Structure; Piperazines; Saccharomyces cerevisiae; Serine Endopeptidases; Topoisomerase II Inhibitors

1994